Cardiovascular safety associated with febuxostat versus allopurinol among patients with gout: Update with accumulated use of febuxostat
Author:
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine,Rheumatology
Reference23 articles.
1. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: The National Health and Nutrition Examination Survey 2007-2016;Chen-Xu;Arthritis Rheumatol,2019
2. Cardiovascular safety of urate lowering therapies;Kang;Curr Rheumatol Rep,2019
3. Cardiovascular safety of febuxostat or allopurinol in patients with gout;White;N Engl J Med,2018
4. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial;Mackenzie;Lancet,2020
5. New perspectives in rheumatology: implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities trial and the associated food and drug administration public safety alert;Choi;Arthritis Rheumatol,2018
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiovascular safety of febuxostat versus allopurinol among the Asian patients with or without gout: A systematic review and meta‐analysis;Clinical and Translational Science;2024-03
2. Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System;Journal of Clinical Medicine;2023-09-20
3. Gout and Cardiovascular Disease: Mechanisms, Risk Estimations, and the Impact of Therapies;Gout, Urate, and Crystal Deposition Disease;2023-08-01
4. POS0189 COMPARATIVE RISK OF RETINAL VASCULAR COMPLICATIONS IN PATIENTS WITH GOUT INITIATING FEBUXOSTAT VERSUS ALLOPURINOL: A POPULATION-BASED COHORT STUDY;Scientific Abstracts;2023-05-30
5. Gout and hyperuricaemia: modifiable cardiovascular risk factors?;Frontiers in Cardiovascular Medicine;2023-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3